Affordable Access

Is post-marketing drug surveillance possible in the family practice setting? A collaborative study.

Authors
  • Facklam, D P
  • Baker, M I
  • Gardner, J S
  • Herbert, C
  • Grava-Gubins, I
Type
Published Article
Journal
Canadian family physician Médecin de famille canadien
Publication Date
Apr 01, 1988
Volume
34
Pages
819–822
Identifiers
PMID: 21253087
Source
Medline
License
Unknown

Abstract

Post-marketing surveillance is a mechanism to identify and quantify harmful, as well as beneficial, effects of drugs used under conditions different from those in which they were tested. The College of Family Physicians of Canada collaborated with the authors in a pilot, office-based, post-marketing, surveillance study. Target medications were selected from all prescriptions, written or authorized by participating physicians. The participants collected the prescriptions by using duplicate prescription pads. Follow-up data was collected from the patients by means of a self-administered questionnaire and from the physicians by means of a medical-chart review. This method of research allows the identification of a cohort of drug users in a systematic, non-biased fashion.

Report this publication

Statistics

Seen <100 times